Shibata, Norio

Contribution of Organofluorine Compounds to Pharmaceuticals

Inoue, M., Sumii, Y., & Shibata, N. (2020) · ACS Omega

Fluorine in Organic ChemistryComputational Drug Discovery Methods

Cited by 1,944

Current Contributions of Organofluorine Compounds to the Agrochemical Industry

Ogawa, Y., Tokunaga, E., Kobayashi, O., Hirai, K., & Shibata, N. (2020) · iScience

Fluorine in Organic ChemistryFungal Plant Pathogen Control

Cited by 1,253

Thalidomide and its metabolite 5‐hydroxythalidomide induce teratogenicity via the cereblon neosubstrate PLZF

Yamanaka, S., Murai, H., Saito, D., Abe, G., Tokunaga, E., Iwasaki, T., Takahashi, H., Takeda, H., Suzuki, T., Shibata, N., et al. (2021) · The EMBO Journal

Protein Degradation and InhibitorsPharmacological Effects and Toxicity Studies

Cited by 89

Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide

Furihata, H., Yamanaka, S., Honda, T., Miyauchi, Y., Asano, A., Shibata, N., Tanokura, M., Sawasaki, T., & Miyakawa, T. (2020) · Nature Communications

Protein Degradation and InhibitorsUbiquitin and proteasome pathways

Cited by 89

Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation

Yamanaka, S., Furihata, H., Yanagihara, Y., Taya, A., Nagasaka, T., Usui, M., Nagaoka, K., Shoya, Y., Nishino, K., Yoshida, S., et al. (2023) · Nature Communications

Protein Degradation and InhibitorsMultiple Myeloma Research and Treatments

Cited by 73

An IMiD-induced SALL4 degron system for selective degradation of target proteins

Yamanaka, S., Shoya, Y., Matsuoka, S., Nishida-Fukuda, H., Shibata, N., & Sawasaki, T. (2020) · Communications Biology

Protein Degradation and InhibitorsUbiquitin and proteasome pathways

Cited by 29